Chronic ischemic mitral regurgitation

Journal of Heart Valve Disease

Volumn 15, Issue 2, 2006, Pages 149-157

  Donal, Erwan ^a   Levy, Franck ^b   Tribouilloy, Christophe ^b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VASODILATOR AGENT;

ANNULOPLASTY; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; DEATH; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; HEART ATRIUM CONTRACTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART PAPILLARY MUSCLE; HUMAN; ISCHEMIC HEART DISEASE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; NONHUMAN; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL MORTALITY; TREADMILL EXERCISE;

CHRONIC DISEASE; ECHOCARDIOGRAPHY, DOPPLER; HEART VENTRICLES; HUMANS; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL ISCHEMIA; PROGNOSIS;

EID: 33645648796     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik J. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction. A quantitative study. Circulation 2000;102:1400-1406
2. Hung J, Otsuji Y, Handschumacher MD, Schwammenthal E, Levine RA. Mechanism of dynamic regurgitant orifice area variation in functional mitral regurgitation. J Am Coll Cardiol 1999;33:538-545
3. Otsuji Y, Handschumacher MD, Liel-Cohen N, et al. Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: Three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol 2001;37:641-648
4. Agricola E, Oppizzi M, Maisano F, et al. Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern. Eur J Echocardiogr 2004;5:326-334
5. Otsuji Y, Kumanohoso T, Yoshifuku S, et al. Isolated annular dilatation does not usually cause important functional mitral regurgitation. J Am Coll Cardiol 2002;39:1651-1656
6. Kwan J, Shiota T, Agler DA, et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation. Circulation 2003;107:1135-1140
7. Green GR, Dagum P, Glasson JR, et al. Mitral annular dilatation and papillary muscle dislocation without mitral regurgitation in sheep. Circulation 1999;100:II-95-II-102
8. Timek TA, Dagum P, Lai DT, et al. Tachycardia-induced cardiomyopathy in the ovine heart: Mitral annular dynamic three-dimensional geometry. J Thorac Cardiovasc Surg 2003;125:315-324
9. Timek TA, Lai DT, Tibayan F, et al. Atrial contraction and mitral annular dynamics during acute atrial and ventricular ischemia in sheep. Am J Physiol Heart Circ Physiol 2002;283:H1929-H1935
10. Nielsen SL, Timek TA, Green GR, et al. Influence of anterior mitral leaflet second-order chordae tendineae on left ventricular systolic function. Circulation 2003;108:486-491
11. Messas E, Guerrero JL, Handschumacher MD, et al. Chordal cutting. A new therapeutic approach for ischemic mitral regurgitation. Circulation 2001;104:1958-1963
12. Liel-Cohen N, Guerrero JL, Otsuji Y, et al. Deign of a new surgical approach for ventricular remodeling to relieve ischemic mitral regurgitation: Insights from three-dimensional echocardiography. Circulation 2000;101:2756-2763
13. Salgo IS, Gorman JH, III, Gorman RC, et al. Effect of annular shape on leaflet curvature in reducing mitral leaflet stress. Circulation 2002;106:711-717
14. Erlebacher JA, Barbarash S. Intraventricular conduction delay and functional mitral regurgitation. Am J Cardiol 2001;88:83-86
15. Abraham WT, Fisher WG, Smith AL, et al. MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853
16. Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026-2033
17. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;41:765-770
18. Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2002;91:684-688
19. Enriquez-Sarano M, Tribouilloy C. Quantitation of mitral regurgitation: Rationale, approach, and interpretation in clinical practice. Heart 2002;88:iv1-iv3
20. Byrne JG, Aklog L, Adams DH. Assessment and management of functional or ischaemic mitral regurgitation. Lancet 2000;355:1743-1744
21. Lebrun F, Lancellotti P, Piérard LA. Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure. J Am Coll Cardiol 2001;38:1685-1692
22. Lancellotti P, Pierard LA. Dynamic echocardiography in mitral insufficiency. Arch Mal Coeur Vaiss 2002;95:793-798
23. Vitarelli A, Gheorghiade M. Transthoracic and transesophageal echocardiography in the hemodynamic assessment of patients with congestive heart failure. Am J Cardiol 2000;86:36-40
24. Iung B. Management of ischaemic mitral regurgitation. Heart 2003;89:459-464
25. Lamas GA, Flaker GC, Mitchell G, et al. Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. Circulation 1995;92:1101-1109
26. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: Long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759-1764
27. Lancellotti P, Troisfontaines P, Toussaint AC, Pierard LA. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation 2003;108:1713-1717
28. Lancellotti P, Lebrun F, Pierard LA. Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2003;42:1921-1928
29. Nemoto S, Hamawaki M, De Freitas G, Carabello BA. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol 2002;40:149-154
30. Levine RA, Hung J. Ischemic mitral regurgitation, the dynamic lesion: Clues to the cure. J Am Coll Cardiol 2003;42:1929-1931
31. Doughty RN, Whalley GA, Walsh HA, Gamble GD, Lopez-Sendon J, Sharpe N. Effects of carvedilol on left ventricular remodelling after acute myocardial infarction. The CAPRICORN Echo substudy. Circulation 2004;109:201-206
32. Trichon BH, Glower DD, Shaw LK, et al. Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation. Circulation 2003;198:II-1036-II-1110.
33. Wu AH, Aaronson KD, Bolling SF, et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005;45:381-387
34. Le Tourneau T, de Groote P, Millaire A, et al. Effect of mitral valve surgery on exercise capacity, ventricular ejection fraction and neurohormonal activation in patients with severe mitral regurgitation. J Am Coll Cardiol 2000;36:2263-2269
35. Hung J, Guerrero L, Handschumacher MD, Supple G, Sullivan S, Levine RA. Reverse ventricular remodelling reduces ischemic mitral regurgitation. Echo-guided device application in the beating heart. Circulation 2002;106:1594-1600.
36. Timek TA, Lai DT, Liang D, et al. Effects of paracommissural septal-lateral annular cinching on acute ischemic mitral regurgitation. Circulation 2004;110(Suppl.I):II79-II184
37. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998;115:381-388
38. Chen FY, Adams DH, Aranki SF, et al. Mitral valve repair in cardiomyopathy. Circulation 1998;98(Suppl.I):II124-II127
39. Radovanovic N, Mihajlovic B, Selestiansky J, et al. Reductive annuloplasty of double orifices in patients with primary dilated cardiomyopathy. Ann Thorac Surg 2002;73:751-755
40. Bax JJ, Braun J, Somer ST, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation 2004;110(Suppl.II):II-103-II-108
41. Haluska BA, Short L, Marwick TH. Relationship of ventricular longitudinal function to contractile reserve in patients with mitral regurgitation. Am Heart J 2003;146:183-188
42. Pu M, Thomas JD, Gillinov MA, Griffin BP, Brunken RC. Importance of ischemic and viable myocardium for patients with chronic ischemic mitral regurgitation and left ventricular dysfunction. Am J Cardiol 2003;92:862-864
43. Aklog L, Filsoufi F, Flores FQ, et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation 2001;104(Suppl.I):I-68-I-75
44. Tcheng JE, Jackman JD, Nelson CL, et al. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med 1992;117:18-24
45. Aklog L, Filsoufi F, Flores KQ, et al. Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation 2001;104:I68-I75
46. Dor V. The endoventricular circular patch plasty ('Dor procedure') in ischemic akinetic dilated ventricles. Heart Fail Rev 2001;6:187-193
47. Liddicoat JR, MacNeill BD, Gillinov AM, et al. Percutaneous mitral valve repair: A feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Intervent 2003;60:410416
48. Kaye DM, Byrne M, Alferness C, Power J. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation. Circulation 2003;108:1795-1797
49. Maniu CV, Patel JB, Reuter DG, et al. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. J Am Coll Cardiol 2004;44:1652-1661
50. Gillinov AM, Wierup PN, Blakstone EH, et al. Is repair preferable to replacement for ischemic mitral regurgitation? J Thorac Cardiovasc Surg 2001;122:1125-1141
51. Otsuji Y, Handschumacher MD, Schwammenthal E, et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: Direct in vivo demonstration of altered leaflet tethering geometry. Circulation 1997;96:1999-2008
52. Hung J, Papakostas L, Tahta SA, et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty. Continued IV remodelling as a moving target. Circulation 2004;110(Suppl.II):II-85-II-90
53. Messas E, Pouzet B, Touchot B, et al. Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation. Circulation 2003;108:II111-II1115
54. Nielsen SL, Timek TA, Green GR, et al. Influence of anterior mitral leaflet second-order chordae tendineae on left ventricular systolic function. Circulation 2003;108:486-491
55. McCarthy PM, Takagaki M, Ochiai Y, et al. Device-based change in left ventricular shape: A new concept for the treatment of dilated cardiomyopathy. J Thorac Cardiovasc Surg 2001;122:482490
56. Sabbah HN. The cardiac support device and the Myosplint: Treatment of heart failure by targeting left ventricular size and shape. Ann Thorac Surg 2003;75:S13-S19
57. Inoue M, McCarthy PM, Popovic ZB, et al. The Coapsys device to treat functional mitral regurgitation in vivo long-term canine study. J Thorac Cardiovasc Surg 2004;127:1068-1076